Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Chinese Patent Office
Federal Trade Commission
Moodys
Cerilliant
Citi
Fish and Richardson
Merck
Dow
Deloitte

Generated: August 22, 2017

DrugPatentWatch Database Preview

ADVIL PM Drug Profile

« Back to Dashboard

Which patents cover Advil Pm, and when can generic versions of Advil Pm launch?

Advil Pm is a drug marketed by Pfizer and is included in two NDAs. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has eleven patent family members in ten countries.

The generic ingredient in ADVIL PM is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.

Summary for Tradename: ADVIL PM

Patents:3
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Clinical Trials: see list25
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADVIL PM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
ADVIL PM
diphenhydramine hydrochloride; ibuprofen
CAPSULE;ORAL021393-001Dec 21, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
Pfizer
ADVIL PM
diphenhydramine hydrochloride; ibuprofen
CAPSULE;ORAL021393-001Dec 21, 2005OTCYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
ADVIL PM
diphenhydramine citrate; ibuprofen
TABLET;ORAL021394-001Dec 21, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ADVIL PM

Drugname Dosage Strength RLD Submissiondate
ibuprofen and diphenhydramine citrateCapsules200 mg/38 mgAdvil PM2/16/2016

International Patent Family for Tradename: ADVIL PM

Country Document Number Estimated Expiration
Canada2434484► Subscribe
World Intellectual Property Organization (WIPO)02056877► Subscribe
Spain2251584► Subscribe
Hong Kong1060045► Subscribe
Germany60207383► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
AstraZeneca
Federal Trade Commission
US Army
US Department of Justice
Mallinckrodt
Novartis
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot